Two years oral use of chlorhexidine in man. VI. Effect on oxidative enzymes inoral epithelia.
D000284:Administration, Oral; D000328:Adult; D001645:Biguanides / Q000009:adverse effects*; D002710:Chlorhexidine / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003773:Dental Plaque / Q000517:prevention & control*; D004341:Drug Evaluation; D004848:Epithelium / Q000201:enzymology; D005260:Female; D005881:Gingiva / Q000201:enzymology; D005954:Glucosephosphate Dehydrogenase / Q000378:metabolism*; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000378:metabolism*; D008291:Malate Dehydrogenase / Q000378:metabolism*; D008297:Male; D009061:Mouth Mucosa / Q000201:enzymology*; D010159:Palate / Q000201:enzymology; D013997:Time Factors
D001645:Biguanides; D007770:L-Lactate Dehydrogenase; D008291:Malate Dehydrogenase; D005954:Glucosephosphate Dehydrogenase; D002710:Chlorhexidine